PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer. - Wikidata - awgldk - TriplyDB

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

http://www.wikidata.org/entity/Q44235056

about

Activin receptor-like kinases: a diverse family playing an important role in cancer PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer.Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma.Up-regulation of PKM2 promote malignancy and related to adverse prognostic risk factor in human gallbladder cancer.Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies.Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis.PKM2 Promotes Cell Survival and Invasion Under Metabolic Stress by Enhancing Warburg Effect in Pancreatic Ductal Adenocarcinoma.Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma.Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma.Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling.Cytosolic PKM2 stabilizes mutant EGFR protein expression through regulating HSP90-EGFR association.

P2860

Q28066886-6D16844B-B9EC-41C3-84E0-FC5BE6183640 Q35176162-686C37C6-1303-401E-B0B5-816E6ABE65A7 Q35571437-1528DCCC-2CC4-45F6-BA40-40FD03CEE907 Q35753643-A882751A-B794-4E6C-9F01-9E7721423C72 Q35962134-4BEF7A93-06CC-41F9-9CF8-B155436D27FD Q36014253-40BA9407-6A84-4BED-9E13-515FCB572A4A Q36261810-E7611E65-4890-4616-818E-A720C765EB46 Q36292690-101BF9CB-5F94-4C10-A4DE-1D3DA3C2ED26 Q36990673-98D1361B-DD36-49B9-AFF9-A17B8197F7F8 Q37109103-5642529E-D355-4328-B3EA-DAE95D9505DC Q37702143-89247DE5-89DB-4F7E-A623-65A49810C71D Q38824976-74457F6D-34DC-4FE5-BD25-17C91FC89F8C Q41345834-AF47CE37-EED4-4696-8575-0D941F1F67BD Q47099754-AAA7668E-27A7-4F9B-9681-BED036962756 Q49888029-30DF2146-A99B-49D6-9665-EAB61177565C Q50920187-53E9836D-861B-41EB-A935-29C39560AEFC

P2860

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

http://www.wikidata.org/entity/Q44235056

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

@en

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

@nl

type

label

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

@en

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

@nl

prefLabel

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

@en

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

@nl

P1433

Q44235056-6075B304-2FA6-4028-A307-7D310953771A

P1476

Q44235056-CC347C20-D08F-48D6-92A8-A68D52E3947D

P2093

Q44235056-385E7800-B891-4194-B30F-E283C21A50BC

Q44235056-58D351AE-7FC1-4824-A3BD-94754640B1A0

Q44235056-70960CE5-0A04-4249-BD79-A5EE647789D1

Q44235056-7883ABAA-6F59-403C-B749-4E3710D0E930

Q44235056-788C25D8-BC69-4002-AC3B-F9CF5C883B3C

Q44235056-87BF9E56-149E-4D5C-9948-A02143FC3105

Q44235056-A1EE6EDD-9D6D-4131-8D54-165BA6889FAA

Q44235056-D43D48C1-9C82-490A-B5B2-C43669D7C34E

P2860

Q44235056-092A4BD3-276A-4916-836B-B0811AACE846

Q44235056-0D4DD661-3C76-449B-808C-47FA2007C0B1

Q44235056-1CBB6F36-6386-4525-B3A7-EF4BFBCD2B66

Q44235056-38A838BC-EDA9-4922-B1F3-D81372C003D5

Q44235056-4EF6438B-CA6F-40CE-8046-989AB56CF149

Q44235056-5CCE9BD6-4875-4227-A42E-1457D4CC6BF3

Q44235056-6724D8FC-60E6-4C2D-9D8E-E5283A7940E3

Q44235056-6BBD8B97-9634-4F84-A81E-442CBD4CA19E

Q44235056-6D504EE9-F6B7-40A2-87DC-3836061A7C23

Q44235056-76431F3D-70E9-4B24-AF35-E5483D47E52E

P2888

Q44235056-EC8734BB-307C-4104-8E8B-0FC7452740DF

P304

Q44235056-EF01A21B-4B28-427C-8E57-444B0FA7CEE9

P31

Q44235056-18330344-3D94-4324-97B8-4C7F91037EE9

P356

Q44235056-0958FD54-0C03-40FA-BBB7-F6177A568FD8

P433

Q44235056-3B19B095-65AD-4C56-940F-692F85F8E8A5

P478

Q44235056-4454FC65-A380-4952-B52D-0B86AA937BA9

P577

Q44235056-9103789B-D535-48A2-9A36-DE8E2A150994

P5875

Q44235056-1D90887B-C4B6-4CB1-A42D-FFEBC6CD4CB4

P698

Q44235056-9DB83990-B4CD-4FB3-A684-E6B16CE4500F

P356

S12094-013-1063-8

P1433

Clinical and Translational Oncology

P1476

PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer.

@en

P2093

G Zeng

http://www.w3.org/2001/XMLSchema#string

J Li

http://www.w3.org/2001/XMLSchema#string

L Liang

http://www.w3.org/2001/XMLSchema#string

Q Zou

http://www.w3.org/2001/XMLSchema#string

S Chen

http://www.w3.org/2001/XMLSchema#string

Y Yuan

http://www.w3.org/2001/XMLSchema#string

Z Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Pyruvate kinase type M2 and its role in tumor growth and spreading

Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells.

Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.

TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect.

Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.

Management of gallbladder cancer.

Activin receptor-like kinase and the insulin gene.

Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation.

Transforming growth factor beta-1 in rectal tumour, mucosa and plasma in relation to radiotherapy and clinical outcome in rectal cancer patients.

Gallbladder cancer: an analysis of a series of 139 patients with invasion restricted to the subserosal layer.

P2888

s12094-013-1063-8

P304

200-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-013-1063-8

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

241694030

http://www.w3.org/2001/XMLSchema#string

P698

23793810

http://www.w3.org/2001/XMLSchema#string